Also trades as: MYND.CN (CNQ) · $vol 0M
MYNDF OTC
MYND Life Sciences Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -41.3%
3Y: -55.0%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$93K
+0.0% ▲
Gross Profit
-$240K
-33.3% ▼
Operating Income
-$2M
+39.1% ▲
Net Income
-$2M
+57.5% ▲
EPS (Diluted)
$-0.03
+58.0% ▲
EBITDA
-$2M
+40.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $93K |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $180K | $333K |
| Gross Profit | $0 | $0 | $0 | -$180K | -$240K |
| Gross Margin | — | — | — | — | -258.1% |
| R&D Expenses | $0 | $0 | $1M | $1M | $282K |
| SG&A Expenses | $3K | $56K | $3M | $2M | $1M |
| Operating Expenses | $3K | $56K | $4M | $3M | $2M |
| Operating Income | -$3K | -$56K | -$4M | -$3M | -$2M |
| Operating Margin | — | — | — | — | -1966.6% |
| Interest Expense | $0 | $0 | $135K | $663K | $732K |
| Income Before Tax | -$3K | -$56K | -$5M | -$4M | -$2M |
| Tax Expense | $0 | $0 | -$168K | -$130K | $0 |
| Net Income | -$3K | -$56K | -$4M | -$4M | -$2M |
| Net Margin | — | — | — | — | -1632.3% |
| EPS (Diluted) | $-0.00 | $-0.00 | $-0.10 | $-0.08 | $-0.03 |
| EBITDA | $0 | $0 | -$4M | -$3M | -$2M |
| Shares Outstanding | 2M | 28M | 45M | 47M | 47M |